Genentech is halting development of an antibody for two rare genetic diseases after the candidate failed to boost muscle growth, raising questions about whether the molecule can preserve muscle in two ...

Intuitive Surgical is recalling one set of its stapler reloads used by its da Vinci robot after incomplete deliveries failed to properly close blood vessels during procedures.  | This comes in the ...

Since Xaira’s eye-popping $1 billion fundraise in 2024, the company has said relatively little in public. | What has Xaira been doing since its $1 billion raise? Xaira COO Jeff Jonker joins "The Top ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. | Renowned cardiologist Eric Topol, M.D., is setting sail with ...

Novartis has struck a front-loaded deal to buy Synnovation Therapeutics’ pan-mutant‑selective PI3Kα inhibitor for $2 billion, ...

Gilead has handed back a next-gen hepatitis B (HBV) antiviral to Assembly Biosciences, while the two companies continue to partner on other assets. It means Assembly is now back in sole control of ABI ...

Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a glo | Embecta ...

Genentech has elected to stop a phase 2 trial of a RIPK1 inhibitor early and dump the asset after an analysis revealed the candidate was unlikely to meet the study’s primary endpoint. | Genentech has ...

About a month after Pfizer CEO Albert Bourla, Ph.D., told investors that the Big Pharma’s pipeline pruning was mostly done, ...

Phage-focused BiomX is undergoing a “strategic and financial reset” in efforts to improve its position, mapping out a possible shift from therapeutics to the defense sector.   | Phage-focused BiomX is ...

North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. | North Carolina-based contract research organization ...

MiniMed is out to prove it deserves the name, with a new FDA clearance for its smallest insulin pump yet.  | At about half the size of the 780G pump, the shape of the 300-unit MiniMed Flex is ...